98 related articles for article (PubMed ID: 28199751)
1. Impact of polymorphisms in angiogenesis-related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinoma.
Ma WL; Liu R; Huang LH; Zou C; Huang J; Wang J; Chen SJ; Meng XG; Yang JK; Li H; Yang GP; Guo CX
Clin Exp Pharmacol Physiol; 2017 May; 44(5):539-548. PubMed ID: 28199751
[TBL] [Abstract][Full Text] [Related]
2. The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma.
Guo C; Huang Y; Yu J; Liu L; Gong X; Huang M; Jiang C; Liao Y; Huang L; Yang G; Li J
Oncotarget; 2017 Apr; 8(15):25334-25344. PubMed ID: 28445979
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma.
Yu J; Huang Y; Liu L; Wang J; Yin J; Huang L; Chen S; Li J; Yuan H; Yang G; Liu W; Wang H; Pei Q; Guo C
Oncotarget; 2016 Dec; 7(50):82528-82537. PubMed ID: 27769064
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the endothelin-1 and endothelin a receptor genes and survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Wen YF; Qi B; Liu H; Mo HY; Chen QY; Li J; Huang PY; Ye YF; Zhang Y; Deng MQ; Guo X; Hong MH; Cao KJ; Mai HQ
Clin Cancer Res; 2011 Apr; 17(8):2451-8. PubMed ID: 21487064
[TBL] [Abstract][Full Text] [Related]
5. Association between XRCC1 single-nucleotide polymorphism and acute radiation reaction in patients with nasopharyngeal carcinoma: A cohort study.
Chen H; Wu M; Li G; Hua L; Chen S; Huang H
Medicine (Baltimore); 2017 Nov; 96(44):e8202. PubMed ID: 29095251
[TBL] [Abstract][Full Text] [Related]
6. Acute oral mucositis in nasopharyngeal carcinoma patients treated with radiotherapy: association with genetic polymorphism in DNA DSB repair genes.
Ren JH; Dai XF; Yan GL; Jin M; Liu CW; Yang KY; Wu G; Ma CM
Int J Radiat Biol; 2014 Mar; 90(3):256-61. PubMed ID: 24350917
[TBL] [Abstract][Full Text] [Related]
7. XRCC3 polymorphisms are associated with the risk of developing radiation-induced late xerostomia in nasopharyngeal carcinoma patients treated with intensity modulation radiated therapy.
Zou Y; Song T; Yu W; Zhao R; Wang Y; Xie R; Chen T; Wu B; Wu S
Jpn J Clin Oncol; 2014 Mar; 44(3):241-8. PubMed ID: 24453273
[TBL] [Abstract][Full Text] [Related]
8. Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinoma.
Guo XB; Ma WL; Liu LJ; Huang YL; Wang J; Huang LH; Peng XD; Yin JY; Li JG; Chen SJ; Yang GP; Wang H; Guo CX
Acta Pharmacol Sin; 2017 Apr; 38(4):571-580. PubMed ID: 28216622
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Guo Q; Lu T; Chen Y; Su Y; Zheng Y; Chen Z; Chen C; Lin S; Pan J; Yuan X
Sci Rep; 2016 Nov; 6():37576. PubMed ID: 27876891
[TBL] [Abstract][Full Text] [Related]
10. Potentially functional variants of autophagy-related genes are associated with the efficacy and toxicity of radiotherapy in patients with nasopharyngeal carcinoma.
Yang Z; Liu Z
Mol Genet Genomic Med; 2019 Dec; 7(12):e1030. PubMed ID: 31692259
[TBL] [Abstract][Full Text] [Related]
11. Potential correlation between EDN1 gene polymorphisms with preeclampsia.
Li J; Yin W; Liu MS; Mao LJ; Wang XH
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1602-1608. PubMed ID: 32141526
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder SP; Hufnagl C; Brechelmacher S; Huemer F; Hackl H; Rinnerthaler G; Romeder F; Monzo Fuentes C; Morre P; Hauser-Kronberger C; Mlineritsch B; Greil R
Pharmacogenomics J; 2017 Jul; 17(4):344-350. PubMed ID: 27139155
[TBL] [Abstract][Full Text] [Related]
13. Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma.
Xie X; Jin H; Hu J; Zeng Y; Zhou J; Ouyang S; Yang W; Hu B; Wang H
Oncol Rep; 2014 Jan; 31(1):223-31. PubMed ID: 24173110
[TBL] [Abstract][Full Text] [Related]
14. Effect of SNP polymorphisms of EDN1, EDNRA, and EDNRB gene on ischemic stroke.
Zhang L; Sui R
Cell Biochem Biophys; 2014 Sep; 70(1):233-9. PubMed ID: 24633486
[TBL] [Abstract][Full Text] [Related]
15. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients.
Liang G; Du W; Ke Q; Huang B; Yang J
Adv Clin Exp Med; 2017; 26(3):409-413. PubMed ID: 28791814
[TBL] [Abstract][Full Text] [Related]
16. MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment.
Tse KP; Tsang NM; Chen KD; Li HP; Liang Y; Hsueh C; Chang KP; Yu JS; Hao SP; Hsieh LL; Chang YS
Clin Cancer Res; 2007 Nov; 13(21):6320-6. PubMed ID: 17975143
[TBL] [Abstract][Full Text] [Related]
17. A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma.
Zheng J; Deng J; Xiao M; Yang L; Zhang L; You Y; Hu M; Li N; Wu H; Li W; Lu J; Zhou Y
Cancer Res; 2013 Aug; 73(16):5151-62. PubMed ID: 23796562
[TBL] [Abstract][Full Text] [Related]
18. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
Ou X; Miao Y; Wang X; Ding J; He X; Hu C
Radiat Oncol; 2017 Aug; 12(1):137. PubMed ID: 28821277
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal.
Sousa H; Mesquita L; Ribeiro J; Catarino R; Breda E; Medeiros R
Immunobiology; 2016 Feb; 221(2):145-52. PubMed ID: 26391153
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variations of
Psoma E; Koliou GA; Dimitrakopoulos FI; Papadopoulou K; Rontogianni D; Bobos M; Visvikis A; Kosmidis PA; Fountzilas G; Constantinidis J; Kalogera-Fountzila A
Anticancer Res; 2020 Feb; 40(2):677-688. PubMed ID: 32014908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
